pediococcus pentosaceus lp28

Cell therapyexperimental

Clinical trial activity

3 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1

Earliest trial started Dec 1, 2013 (NCT02050555)

Timeline

No events for the selected filters.

Indications

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • pediococcus pentosaceus lp28

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06724185N/AJul 9, 2024Synbio Tech
NCT04304014Phase 4Mar 5, 2020University of Barcelona
NCT02050555N/ADec 1, 2013Hiroshima University, Marukome Co., Ltd.
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Hiroshima UniversityAcademic/Hospital1112013
Marukome Co., Ltd.For profit1012013
Synbio TechFor profit1112024
University of BarcelonaAcademic/Hospital1112020
4 organizations
Page 1 / 1